GARRIBBA, Eugenio
 Distribuzione geografica
Continente #
NA - Nord America 10.940
AS - Asia 6.218
SA - Sud America 3.615
EU - Europa 3.190
AF - Africa 260
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 11
Totale 24.251
Nazione #
US - Stati Uniti d'America 10.705
BR - Brasile 3.216
SG - Singapore 2.623
CN - Cina 1.714
UA - Ucraina 1.154
HK - Hong Kong 579
DE - Germania 487
VN - Vietnam 418
SE - Svezia 329
FI - Finlandia 249
FR - Francia 238
IT - Italia 201
GB - Regno Unito 185
AR - Argentina 134
TR - Turchia 131
BD - Bangladesh 106
MX - Messico 103
IN - India 93
IQ - Iraq 90
CA - Canada 83
RU - Federazione Russa 75
ZA - Sudafrica 67
EC - Ecuador 63
VE - Venezuela 59
UZ - Uzbekistan 57
JP - Giappone 56
MA - Marocco 56
CO - Colombia 47
PL - Polonia 44
ID - Indonesia 43
PK - Pakistan 41
ES - Italia 38
NL - Olanda 37
KR - Corea 31
KE - Kenya 29
PY - Paraguay 28
AZ - Azerbaigian 25
JO - Giordania 24
OM - Oman 22
UY - Uruguay 22
AE - Emirati Arabi Uniti 20
BE - Belgio 20
NP - Nepal 20
PE - Perù 19
CL - Cile 18
SA - Arabia Saudita 18
CZ - Repubblica Ceca 17
EG - Egitto 17
KZ - Kazakistan 17
TN - Tunisia 17
DZ - Algeria 16
AT - Austria 15
AU - Australia 15
PH - Filippine 15
RS - Serbia 13
HN - Honduras 12
JM - Giamaica 12
LT - Lituania 12
IL - Israele 10
SN - Senegal 10
AO - Angola 9
BY - Bielorussia 9
EU - Europa 8
LB - Libano 8
PS - Palestinian Territory 8
CH - Svizzera 7
DO - Repubblica Dominicana 7
GA - Gabon 7
MY - Malesia 7
PT - Portogallo 7
RO - Romania 7
AL - Albania 6
BO - Bolivia 6
ET - Etiopia 6
GE - Georgia 6
GR - Grecia 6
IE - Irlanda 6
KG - Kirghizistan 6
NG - Nigeria 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
CG - Congo 5
CR - Costa Rica 5
QA - Qatar 5
EE - Estonia 4
IR - Iran 4
PA - Panama 4
SY - Repubblica araba siriana 4
BG - Bulgaria 3
CI - Costa d'Avorio 3
GT - Guatemala 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BW - Botswana 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
Totale 24.219
Città #
Dallas 3.990
Singapore 1.438
Chandler 1.222
San Jose 855
Jacksonville 670
Hong Kong 572
Ashburn 467
Princeton 415
Beijing 307
Nanjing 256
São Paulo 239
Dearborn 235
Lauterbourg 203
Wilmington 183
Ho Chi Minh City 143
Shanghai 140
Boardman 118
Hanoi 108
Santa Clara 99
Nanchang 97
Los Angeles 96
Rio de Janeiro 91
Ann Arbor 85
Belo Horizonte 84
Tianjin 80
New York 77
Helsinki 71
Woodbridge 65
Shenyang 64
Council Bluffs 62
Brasília 58
Columbus 57
Tokyo 54
Hebei 53
Tashkent 53
Sassari 50
Changsha 47
Curitiba 47
Frankfurt am Main 47
The Dalles 47
Jiaxing 46
Campinas 44
San Francisco 42
Baghdad 39
Izmir 39
Mountain View 37
Warsaw 37
Jinan 35
Norwalk 35
Falls Church 34
Porto Alegre 32
Salvador 32
Zhengzhou 32
Hangzhou 31
Johannesburg 30
Kunming 30
Orem 30
Seoul 30
Ningbo 29
Andover 28
Montreal 28
Amsterdam 27
Munich 27
Atlanta 26
Buffalo 26
Campo Grande 26
Santo André 26
Baku 25
Guarulhos 25
Nairobi 25
São José dos Campos 25
Denver 24
Dhaka 24
Falkenstein 24
London 24
Toronto 24
Amman 23
Sorocaba 23
Chennai 22
Goiânia 22
Quito 22
Ribeirão Preto 21
Haiphong 20
Houston 20
Manaus 20
Montevideo 20
Recife 20
Stockholm 20
Brooklyn 19
Brussels 19
Fortaleza 19
Guangzhou 19
Caracas 18
Istanbul 18
Jakarta 18
Muscat 18
Cape Town 17
Florianópolis 17
Phoenix 17
Mexico City 16
Totale 14.611
Nome #
Speciation and structural transformation of a VV–malate complex in the absence and in the presence of a protein: from a dinuclear species to decavanadate 287
Controlling intramolecular electronic communication through the conformation changes via stepwise oxidations in dicopper(ii) and dinickel(ii) porphyrin dimers 235
Exploiting the potential of rivastigmine-melatonin derivatives as multitarget metal-modulating drugs for neurodegenerative diseases 230
Bioinspired Oxidized Dicobalt Porphyrin Dimer-Catalyzed Cycloaddition Reactions: Cooperative Catalysis and Spectroscopic and Mechanistic Investigation 196
A Multi-Technique Investigation of the Complex Formation Equilibria between Bis-Deferiprone Derivatives and Oxidovanadium (IV) 182
A hexanucluear copper(II) Schiff base complex incorporating rare “bicapped cubane” core: Structural aspects, magnetic properties and EPR study 178
Co-ordination Ability of Cu2+ ion toward the Nucleobase-Amino Acid Willardiine 177
A 2-D coordination polymer incorporating cobalt(II), 2-sulfoterephthalate and the flexible bridging ligand 1,3-di(4-pyridyl)propane 164
5,5′-Dibenzoimidazole as building block for a new 3D Co(II) coordination polymer: A combined EPR and DFT study using UB3LYP model 154
A trigonal prismatic anionic iron(III) complex of a radical o-iminobenzosemiquinonate derivative: Structural and spectral analyses 153
Binding of oxovanadium(IV) to imidazole, pyrazole and thiazole ligands 152
A novel mixed valent CuII–CuI 2D framework made of a hydrazone and μ-SCN bridged metallacyclic loops cross-linked by μ3-SCN chains 151
A novel μ1,1-azido-, μ2-alkoxo-, and μ2-phenoxo-bridged tetranuclear copper(II) complex with a quinquedentate Schiff-base ligand: magneto-structural and DFT studies 151
Vanadium(IV,V) complexes of D-saccharic and mucic acids in aqueous solution 146
Biorelevant reactions of the potential anti-tumor agent vanadocene dichloride 146
A New CuII Coordination Polymer: Structural Elucidation, EPR and Sensing Studies for Detection of Volatile Organic Solvents 145
A rare cobalt(III) paramagnetic derivative incorporating 1-alkyl-2-[(o-thioalkyl)phenylazo]imidazole (SMeaaiNEt): EPR, redox and magnetic interpretation 144
A Ni(II) derivative incorporating tetradentate Schiff base precursor: Structure, spectral, electrochemical and DFT interpretation 144
A mixed valent heterometallic Cu-II/Na-I coordination polymer with sodium–phenyl bonds 142
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 1. Coordination modes and geometry in solution and at the physiological pH 142
End-to-end thiocyanato-bridged zig-zag polymers of CuII, CoII and NiII with a hydrazone ligand: EPR, magnetic susceptibility and biological study 139
Temperature and solvent structure dependence of VO2+ complexes of pyridine-N-oxide derivatives and their interaction with human serum transferrin 138
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 138
A Trimetallic Cu(II) Derivative as an Efficient and Stable Electrocatalyst for Reduction of Proton to Molecular Hydrogen 138
Synthesis of Two New Linear Trinuclear CuII Complexes: Mechanism of Magnetic Coupling through Hybrid B3LYP Functional and CShM Studies 137
A new linear double phenoxide-bridged trinuclear Cu(II) Schiff base complex: Synthesis, crystallographic elucidation, magneto-structural 137
A quantitative study of the biotransformation of insulin-enhancing VO(2+) compounds 136
Covalent and non-covalent binding in vanadium–protein adducts 135
An enolato-bridged dinuclear Cu(II) complex with a coumarin-assisted precursor: a spectral, magnetic and biological study 132
Binding of VIVO2+ to the Fe binding sites of human serum transferrin. A theoretical study 132
Speciation in aqueous solution and interaction with low and high molecular mass blood bioligands of [VIVO(oda)(H2O)2], a V compound with in vitro anticancer activity 132
A Ni(II) dinuclear complex bridged by end-on azide-N and phenolate-O atoms: spectral interpretation, magnetism and biological study 132
Binding of Oxovanadium(IV) to Dipeptides containing Histidine and Cysteine Residues 131
Interaction of antidiabetic vanadium compounds with hemoglobin and red blood cells and their distribution between plasma and erythrocytes 130
Synthesis of Nitric Oxide Donors Derived from Piloty’s Acid and Study of Their Effects on Dopamine Secretion from PC12 Cells 130
Formation of Mixed‐Valence Cage‐Like Polyoxidovanadates at 37°C Upon Reaction of VIVO(acetylacetonato)2 With Lysozyme 129
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 129
Elucidation of Binding Site and Chiral Specificity of Oxidovanadium Drugs with Lysozyme through Theoretical Calculations 129
Synthesis and characterization of vanadium(IV) complexes with cis-inositol in aqueous solution and in the solid-state 128
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 128
A New phenoxido/trifluoroacetato bridged heterometallic Ni II2 –Cu II derivative: Structure, EPR interpretation and DFT computation 127
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 127
Nonoxido VIV complexes: Prediction of the EPR spectrum and electronic structure of simple coordination compounds and amavadin 126
Chemistry of oxidomolybdenum(IV) and -(VI) complexes with ONS donor ligands: Synthesis, computational evaluation and oxo-transfer reactions 126
Speciation of potential anti-diabetic vanadium complexes in real serum samples 125
Binding of potential antitumor Casiopeínas® to small proteins 124
A new Ni(II) coordination polymer formed by bulky bis(imidazole) and 4,4′-oxybis(benzoic acid): Topological and spectral elucidation 123
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 122
Simple Coordination Geometry Descriptors Allow to Accurately Predict Metal-Binding Sites in Proteins 122
Cobalt(II), manganese(IV) mononuclear and zinc(II) symmetric dinuclear complexes of an aliphatic hydrazone Schiff base ligand with diversity in coordination behaviors and supramolecular architectures: syntheses, structural elucidations, and spectroscopic characterizations 121
Oxovanadium(IV) binding to ligands containing donor sites of biological relevance 121
Integrated ESI-MS/EPR/computational characterization of the binding of metal species to proteins: vanadium drug–myoglobin application 120
Complex formation between [(η6-p-cym)Ru(H2O)3]2+ and oligopeptides containing three histidyl moieties 120
Physicochemical, antioxidant, DNA cleaving properties and antimicrobial activity of fisetin-copper chelates 119
Synthesis, structure, physicochemical characterization and theoretical evaluation of non-covalent interaction energy of a polymeric copper(II)-hydrazone complex 119
Vanadium and proteins: Uptake, transport, structure,activity and function 117
Bis- and tris(pyridyl)amine-oxidovanadium complexes: characteristics and insulin-mimetic potential 116
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 116
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug 116
Solution speciation and spectral studies on oxovanadium(IV) complexes of pyridinecarboxylic acids 115
A rare doubly nitrato and phenoxido bridged trimetallic CuIIcomplex: EPR, antiferromagnetic coupling and theoretical rationalization 114
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 114
VIVO Complexes of Bis(imidazol-2-yl) Derivatives: a Potentiometric, Spectroscopic and DFT Study 113
Electronic structure of oxovanadium(IV) complexes of alpha-hydroxycarboxylic acids 113
V(IV)O complexes with bis(pyridyl) derivatives 113
Effect of temperature and ligand protonation on the electronic ground state in Cu(ii) polymers having unusual secondary interactions: a magnetic and catechol oxidase study 113
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 113
Interaction of a chelating agent, 5-hydroxy-2-(hydroxymethyl)pyridin-4(1 H )-one, with Al(III), Cu(II) and Zn(II) ions 113
Coordination modes of hydroxamic acids in copper(II), nickel(II) and zinc(II) mixed-ligand complexes in aqueous solution 112
Behavior of the potential antitumor VIVO complexes formed by flavonoid ligands. 2. Characterization of sulfonate derivatives of quercetin and morin, interaction with the bioligands of the plasma and preliminary biotransformation studies 111
Coordination ability and biological activity of a naringenin thiosemicarbazone 110
Structural elucidation, EPR and magnetic property of a Co(III) complex salt incorporating 4,4′-bipyridine and 5-sulfoisophthalate 110
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 110
Interaction of VO2+ ion with human serum transferrin and albumin 110
The equilibrium between the octahedral and square pyramidal form in VIVO complexes and the influence of an axial ligand on their molecular properties: a spectroscopic and DFT study 110
Interaction of VVO2−hydrazonates with lysozyme 109
New developments in the comprehension of the biotransformation and transport of insulin-enhancing vanadium compounds in the blood serum 109
Synthesis and characterization of the chemical properties of new classes of NO donors as potential dopamine releasers in the treatment of Parkinson’s disease 109
Synthesis, structural aspects and magnetic properties of an unusual 2D thiocyanato-bridged cobalt(II)-Schiff base network 108
Oxovanadium(IV) complexes with pyrazinecarboxylic acids: The coordinating properties of ligands with the (N-aromatic, COO-) donor set 107
Vanadium 107
Role of Ligands in the Uptake and Reduction of V(V) Complexes in Red Blood Cells 107
Thermodynamic Study of Oxidovanadium(IV) with Kojic Acid Derivatives: A Multi-Technique Approach 107
Determination of the hyperfine coupling constant and zero-field splitting in the ESR spectrum of Mn2+ in calcite 106
Ferromagnetic exchange coupling in a new bis(l-chloro)-bridged copper(II) Schiff base complex: synthesis, structure, magnetic properties and catalytic oxidation of cycloalkanes 106
Chelating ability and biological activity of hesperetin Schiff base 106
Bulky bis(imidazole) and 2-sulfoterephthalate Assisted 3-D Cu(II) and 2-D Mn(II) Coordination Polymers: Topology, Diversity in Metal Containing Nodes and Spectral Elucidation 106
Application of DFT Methods in the Study of (VO2+)-O-IV-Peptide Interactions 106
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 105
Copper(II) complexes of imidazolinone herbicides 105
The determination of the geometry of Cu(II) complexes - An EPR spectroscopy experiment 105
Accurate prediction of vertical electronic transitions of Ni(II) coordination compounds via time dependent density functional theory 105
Interaction of Vanadium(IV) Species with Ubiquitin: A Combined Instrumental and Computational Approach 105
Design of nalidixic acid‑vanadium complex loaded into chitosan hybrid nanoparticles as smart strategy to inhibit bacterial growth and quorum sensing 105
Interaction between the low molecular mass components of blood serum and the VO(IV)-DHP system (DHP=1,2-dimethyl-3-hydroxy-4(1H)-pyridinone) 105
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 104
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 104
Ternary complex formation between VO(IV)-picolinic acid or VO(IV)-6-methylpicolinic acid and small blood serum bioligands 104
Uptake of potential anti-diabetic VIVO compounds of picolinate ligands by red blood cells 104
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 103
Totale 12.827
Categoria #
all - tutte 98.481
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.481


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021298 0 0 0 0 0 0 0 0 0 227 37 34
2021/2022988 132 0 1 13 41 26 47 83 103 54 95 393
2022/20232.201 231 140 45 392 214 388 2 268 380 18 72 51
2023/2024538 122 74 16 37 87 25 8 17 8 5 52 87
2024/20256.599 47 73 374 113 225 244 525 1.312 2.340 866 274 206
2025/202610.019 313 2.232 2.412 1.252 801 588 1.376 300 390 355 0 0
Totale 24.624